Menu
Not yet recruiting NCT07403448

Effects of 9 Points Electrical Dry Needling in Knee Osteoarthritis

No phase Interventional Knee Arthritis Osteoarthritis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 9 points electrical dry needling, Standard physical therapy.
Who it may be relevant to
Registry conditions: Knee Arthritis Osteoarthritis. Basic parameters: 40 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of 9 Points Electrical Dry Needling on Pain, Range of Motion, Function and Quality of Life in Patients With Knee Osteoarthritis

Overview

The study will be conducted to compare effects of 9 points electrical dry needling along with standard physical therapy and standard physical therapy alone in knee osteoarthritis patients.

Interventions

  • Other 9 points electrical dry needling
    9 points electrical dry needling, stainless steel dry needles of size 0.25 into 30mm will be used, inserted perpendicularly into popliteus, adductor magnus, tibialis anterior, quad tendon, vastus lateralis, medialis, medial \& lateral infrapatellar sulcus, extensor digitorum longus.
  • Other Standard physical therapy
    Standarized physical therapy: HOT pack for 5 min, hams \& quads stretching for 30 sec \& 6 reps, quads strengthening straight leg raise \& leg press will be performed 15 reps \& 3 sets, for hams seated leg curls \& gluteal bridges will be performed 15 reps \& 3 sets. MWM in weight bearing position: The glide will be applied in weight bearing, effected knee on stepper, the therapist will be exactly sitting in front of the patient \& patient will be asked to place the limb up on the stepper one h

Primary outcome measures

  • Numeric Pain Rating Scale (NPRS) [Time frame: from enrollment to the end of 6 week]
  • Goniometer measures joint range of motion (ROM) [Time frame: from enrollment to the end of 6 week]
  • WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) [Time frame: from enrollment to the end of 6 week]
  • EQ-5D 3L (QUALITY OF LIFE) [Time frame: From enrollment to the end of 6 week]

Eligibility criteria

Inclusion criteria

  • participants age group from 40-60 years
  • Both male and female genders
  • Knee osteoarthritis (OA) confirmed by radiographic evidence (Kellgren- Lawrence grade 3).
  • Numerical Pain Rating Scale (NPRS) ≥ 4/10.
  • Able to stand and bear weight on affected knee.
  • WOMAC score > 25 moderate level of difficulty performing ADL
  • Participant with restricted range of motion
  • Pain while walking and ascending stairs
  • Patients volunteered to participate in the study and signed informed consent

Exclusion criteria

  • Mild to severe knee osteoarthritis (Kellgren-Lawrence grade 2 or 4).
  • Recent knee surgery or injection (<6 months).
  • Knee instability and ligamentous injury.
  • Pregnancy and breastfeeding.
  • Patient with needle phobia and with history of abnormal reaction to needles.
  • Diagnosed psychological disorders
  • Anticoagulant patient, tumors and hematomas.
  • All acute emergencies and acute systematic fevers.
  • Pacemakers and implantable cardioverter defibrillators

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Sheikh Khalifa Bin Zayed Hospital, Quetta — Quetta

Identifiers

NCT: NCT07403448 · REC/RCR & AHS/24/0197

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗